Most Ditch GLP-1 Drugs for Weight Loss Within a Year

(MedPage Today) — Just over half of patients with overweight or obesity discontinued their GLP-1 receptor agonist within 1 year, with rates even higher among the subset without type 2 diabetes, according to a retrospective cohort study.
Among…

Source link : https://www.medpagetoday.com/endocrinology/obesity/114023

Author :

Publish date : 2025-01-31 16:00:00

Copyright for syndicated content belongs to the linked Source.